Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qansy Salako"'
Autor:
Sui Shen, Linda A. Kroger, Jerry P. Lewis, Gerald L. DeNardo, John P. McGahan, Qansy Salako, Sally J. DeNardo, Desiree S. Goldstein, Norman B. Levy, Kathleen R. Lamborn
Publikováno v:
Journal of Clinical Oncology. 16:3246-3256
PURPOSE Lym-1, a monoclonal antibody that preferentially targets malignant lymphocytes, has induced remissions in patients with non-Hodgkin's lymphoma (NHL) when labeled with iodine 131 ((131)I). Based on the strategy of fractionating the total dose,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01aea7a332a19d79fd1408c4c9d006a8
https://doi.org/10.1200/jco.1998.16.10.3246
https://doi.org/10.1200/jco.1998.16.10.3246
Autor:
Qansy Salako, Sally J. DeNardo
Publikováno v:
Health Physics. 72:56-59
Large hospitals and biomedical research centers utilize decay-in-storage programs to minimize the volume of their low level radioactive waste. However, some medically useful radionuclides often contain small amounts of long-lived radionuclidic impuri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c87fb1704b933e708071544dc8678d0
https://doi.org/10.1097/00004032-199701000-00008
https://doi.org/10.1097/00004032-199701000-00008
Autor:
Sally J. DeNardo, P B S Douglas Greiner, L B S David Kukis, Habibe Diril, Gerald L. DeNardo, Claude F. Meares, Qansy Salako
Publikováno v:
Cancer. 73:779-786
Background. The development of new chelating agents and radiolabeling protocols is essential to progress in radioimmunotherapy with antibody-chelate conjugates. Methods. Immunoconjugates of four polyazamacrocycles with N-bonded acetate groups were pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ddf0fb269469eb55629ea1bf0c87412
https://doi.org/10.1002/1097-0142(19940201)73:3+<779::aid-cncr2820731306>3.0.co
https://doi.org/10.1002/1097-0142(19940201)73:3+<779::aid-cncr2820731306>3.0.co
Autor:
Claude F. Meares, Laird Miers, Sui Shen, I. Fand, Sally J. DeNardo, David L. Kukis, Qansy Salako, Linda A. Kroger, Oliver Renn, Gerald L. DeNardo
Publikováno v:
Cancer. 73:1012-1022
Background. BrE-3 is a monoclonal antibody that has promise for imaging and therapy of human adenocarcinoma. Because of observations in therapeutic trials of yttrium-90 ( 90 Y) escape from radioimmunoconjugates and uptake by the skeleton with resulta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a977bc40add1bc39c726334a112230fa
https://doi.org/10.1002/1097-0142(19940201)73:3+<1012::aid-cncr2820731340>3.0.co
https://doi.org/10.1002/1097-0142(19940201)73:3+<1012::aid-cncr2820731340>3.0.co
Autor:
L F O Grady, Qansy Salako, Sally J. DeNardo, Elissa L. Kramer, Gerald L. DeNardo, K A Warhoe, C M Rlchman, R L Ceriani, Stanley L. Mills
Publikováno v:
Clinical Nuclear Medicine. 17:761
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b07cd7a6d3d385966f251e4b0aac83f1
https://doi.org/10.1097/00003072-199209000-00033
https://doi.org/10.1097/00003072-199209000-00033